NT 10-K
1
formnt10-k.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
(Check
One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q
☐ Form N-SAR ☐ Form N-CSR
For
Period Ended: March 31, 2025
☐ Transition Report on Form 10-K
☐ Transition Report on Form 20-F
☐ Transition Report on Form 11-K
☐ Transition Report on Form 10-Q
☐
Transition Report on Form N-SAR
For
the Transition Period Ended:
Read
Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing
in this form shall be construed to imply that the Commission
has
verified any information contained herein.
If
the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
PART
I - REGISTRANT INFORMATION
BIOTRICITY
INC.
Full
name of Registrant
N/A
Former
Name if Applicable
203
Redwood Shores Parkway, Suite 600
Address
of Principal Executive Office (Street and Number)
Redwood
City, CA 94065
City,
State and Zip Code
PART
II - RULE 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate.)
(a)
The reasons described in reasonable
detail in Part III of this form could not be eliminated without unreasonable effort or expense;
☒
(b)
The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR, or Form N-CSR, or portion thereof, will be filed on or before the fifteenth
calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed due date; and
(c)
The accountant’s statement or other exhibit required
by Rule 12b-25(c) has been attached if applicable.
PART
III - NARRATIVE
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report portion thereof could
not be filed within the prescribed time period.
The
compilation, dissemination and review of the information required to be presented in the Form 10-K for the relevant period has imposed
time constraints that have rendered timely filing of the Form 10-K impracticable without undue hardship and expense to the registrant.
The registrant undertakes the responsibility to file such report no later than fifteen days after its original prescribed due date.
PART
IV - OTHER INFORMATION
(1)
Name and telephone
number of person to contact in regard to this notification
John Ayanoglou
(800)
590-4155
(Name)
(Area Code)
(Telephone Number)
(2)
Have all other
periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been
filed? If the answer is no, identify report(s). Yes ☒ No ☐
(3)
Is it anticipated
that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by
the earnings statements to be included in the subject report or portion thereof? Yes ☐ No ☒
If
so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why
a reasonable estimate of the results cannot be made.
BIOTRICITY
INC.
(Name
of Registrant as Specified in Charter)
Has
caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
Date:
June 30, 2025
By:
/s/ John Ayanoglou
John Ayanoglou
Chief Financial Officer